Current knowledge of Lyme disease’s pathogenesis
https://doi.org/10.22625/2072-6732-2012-4-2-5-14
Abstract
This review present current immunological, microbiological and molecular genetic features of Lyme disease. The mechanisms of borrelia’s dissemination and adaptation in the macroorganism are describe. The role of B. burgdorferi s.l. in the development of autoimmune diseases and non-Hodgkin-lymfomas is describe.
About the Authors
N. V. SkripchenkoRussian Federation
A. A. Balinova
Russian Federation
References
1. Агафьина, А.С. Сборник статей по применению препарата цитофлавин (2002–2006) / А.С. Агафьина, С.В. Михеев. – СПб., 2006. – 104 с.
2. Васильева, Ю.П. Клинико-иммунологические критерии хронизации иксодового клещевого боррелиоза у детей : автореф. дис. …канд. мед. наук / Ю.П. Васильева. – СПб.: НИИДИ, 2003. – 20 с.
3. Воробьева, Н.Н. Клиника, лечение и профилактика иксодовых клещевых боррелиозов. – Пермь: Урал-Пресс, 1998. – 136 с.
4. Воробьева, Н.Н. Нарушение системы гемостаза и микроциркуляции при болезни Лайма / Н.Н.Воробьева [и др.] // Проблемы клещевых боррелиозов. – М., 1993. – С. 81–82.
5. Иванова, Г.П. Разработка клинико-лабораторной диагностики и лечения иксодового клещевого боррелиоза у детей : автореф. дис. …канд. мед. наук / Г.П. Иванова. – СПб.: НИИДИ, 1999. – 22 с.
6. Иксодовые клещевые боррелиозы у детей и взрослых : методические рекомендации для врачей / Ю.В.Лобзин [и др.]. – СПб, 2010. – 64 с.
7. Козлов, С.С. Лайм-боррелиоз в Северо-Западном регионе России : автореф. дис. …д-ра мед. наук / С.С. Козлов. – СПб.: ВМеДА,1999. – 39 с.
8. Лобзин, Ю.В. Лайм-боррелиоз (иксодовые клещевые боррелиозы) / Ю.В. Лобзин, А.Н. Усков, С.С. Козлов – СПб.: Фолиант, 2000. – 160 с.
9. Малеев, В.В. Нарушения гемостаза при инфекционных заболеваниях / В.В. Малеев, А.М. Поляков, А.В. Кравченко. – М.: Де Ново, 2005. – 151 с.
10. Муравина,Т.И. Клинический,нейрофизиологически й, иммуногенетический анализ нейроборрелиоза : автореф. дис. …канд. мед. наук / Т.И. Муравина. – М.: НИИ неврологии РАН, 2001. –30 с.
11. Оберт, А.С. Иксодовые клещевые боррелиозы: Нозогеографические и медико-экологические аспекты /А.С. Оберт, В.Н. Дроздов, С.А. Рудакова. – Новосибирск: Наука, 2001. – 110 с.
12. Скрипченко, Н.В. Клещевые инфекции у детей : руководство для врачей / Н.В. Скрипченко Г.П. Иванова. – М.: ОАО «Издательство Медицина», 2008. – 424 c.
13. Усков, А.Н. Смешанные инфекции, передающиеся иксодовыми клещами, в Северо-Западном регионе России (клиника, диагностика, лечение) : автореф. дис. …д-ра мед. наук / А.Н. Усков. – СПб.: ВМеДА, 2003. – 43 с.
14. Aberer, E. Why is chronic Lyme borreliosis chronic? // E. Aberer, F. Koszik, M. Silberer // Clin. Infect. Dis. – 1997. – № 25. – Р. 64–70.
15. Agarwal, R. Neuro-lyme disease: MR imaging findings /R. Agarwal, G. Sze // Radiology. – 2009. – V. 253, №1. –Р. 167–173.
16. Alaedini, A. Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue / A. Alaedini, N. Latov // J. Neuroimmunol. – 2005. – № 159(1–2). – Р. 192–195.
17. Alban, S.P. Serum starvation induced changes in protein synthesis and morphology of Borrelia burgdorferi // S.P. Alban [et al.] // Microbiology. – 2000. – № 146. – Р. 119–127.
18. Alitalo, A. Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs / A. Alitalo [et al.] // J. Immunol. – 2002. – № 169. – Р. 3847–3853.
19. Anderson, J.F. Epizootiology of Lyme borreliosis / J.F. Anderson // Scand. J. Infect. Dis. – 1991. – № 77. – Р. 23–34.
20. Auwaerter, P.G. Lyme borreliosis (Lyme disease): molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment / P.Auwaerter [et al.] // Expert. Rev. Mol. Med. – 2004. – V. 6, № 2. – Р. 1–22.
21. Barbour, A.G. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness / A.G. Barbour, G.O. Maupin, G.J. Teltow // J. Infect. Dis. – 1996. – V.173, № 2. – Р. 403–409.
22. Bockenstedt, L.K. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibio tic treatment / L.K. Bockenstedt [et al.] // J. Infect. Dis. – 2002. – № 186. – Р. 1430–1437.
23. Brandes, M. Activation-dependent modulation of B lymphocyte migration to chemokines / M. Brandes [et al.] // Int. Immunol. – 2000. – № 12. – Р. 1285–1292.
24. Brorson, O. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine / O. Brorson, S.H. Brorson // Int. Microbiol. – 2002. – V.5, №1. – Р. 25–31.
25. Brorson, O. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H media // O. Brorson, S.H. Brorson // Infection. – 1998. – № 26. – Р. 144–150.
26. Casjens, S. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi / S. Casjens, N. Palmer, R. van Vugt // Mol. Microbiol. – 2000. – № 35. – Р. 490–516.
27. Cassatt, D.R. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies / D.R. Cassatt [et al.] // Infect. Immun. – 1998. – № 66. – Р. 5379–5387.
28. Cerar, T. Humoral immune responses in patients with Lyme neuroborreliosis / T Cerar [et al.] // Clin. Vaccine Immunol. – 2010. – V.7, № 4. – Р.645–650.
29. Christen, H.J. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis / H.J. Christen [et al.] // Acta Paediatr. Suppl. – 1993. – № 386. – Р. 1–75.
30. Coleman, J.L. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice / J.L. Coleman, J.A. Gebbia, J. Piesman // Cell. – 1997. – № 89. – Р. 1111–1119.
31. Comstock, L.E. Penetration of endothelial cell monolayers by Borrelia burgdorferi / L.E. Comstock, D.D. Thomas // Infect Immun. – 1989. – V.57, №5. – Р. 1626–1628.
32. Daix, V. Ixodes ticks belonging to the Ixodes ricinus complex encode a family of anti-complement proteins / V. Daix [et al.] // Insect. Mol. Biol. – 2007. – № 16. – Р. 155–166.
33. Dennis, D.T. Epidemiology of Lyme Borreliosis. In Lyme borreliosis: biology, epidemiology and control / D.T. Dennis [et al.] // CABI Publishing. – 2002. – Р. 251–280.
34. Ebnet, K. Borrelia burgdorferi activates nuclear factor-κ B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts / K. Ebnet [et al.] // J. Immunol. – 1997. – № 158. – Р. 285–292.
35. Ekdahl, K.N. Immunity in borreliosis with special emphasis on the role of complement / K.N. Ekdahl [et al.] // Adv. Exp. Med. Biol. – 2007. – № 598. – Р. 198–213.
36. Feng, S. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice / S. Feng [et al.] // Infect. Immun. – 1998. – № 66. – Р. 2827–2835.
37. Fingerle, V. Complementation of a Borrelia afzelii OspC mutant highlights the crucial role of OspC for dissemination of Borrelia afzelii in Ixodes ricinus / V. Fingerle [et al.] // Int. J. Med. Microbiol. – 2007. – № 297. – Р. 97–107.
38. Fraenkel, C.J. Determination of novel Borrelia genospecies in Swedish Ixodes ricinus ticks / C.J. Fraenkel, U. Garpmo, J.J. Berglund // Clin. Microbiol. – 2002. – V.40, № 9. – Р. 3308–3312.
39. Froude, J. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry
40. and autoimmunity / J. Froude, A. Gibofsky, D.R. Buskirk // Curr. Top. Microbiol. Immunol. – 1989. – № 145. – Р. 5–26.
41. Fukunaga, M. Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan / М. Fukunaga [et al.] // Int. J. Syst. Bacteriol. – 1995. – V. 45, №4. – Р. 804–810.
42. Gajdusek, D.C. Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system / D.C. Gajdusek // N. Engl. J. Med. – 1985. – № 312. – Р. 714–719.
43. Giambartolomei, G.H. Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys / G.H. Giambartolomei, V.A. Dennis, M.T. Philipp // Infect. Immun. – 1998. – № 66. – Р. 2691–2697.
44. Gilbert, M.A. Artificial regulation of ospC expression in Borrelia burgdorferi / M.A. Gilbert [et al.] // Mol. Microbiol. – 2007. – № 63. – Р. 1259–1273.
45. Girschick, H.J. Intracellular persistence of Borrelia burgdorferi in human synovial cells / H.J. Girschick [et al.] // Rheumatol. Int. – 1996. – № 16. – Р. 125–132.
46. Hulinska, D. Electron microscopy of Langerhans cells and Borrelia burgdorferi in Lyme disease patients / D. Hulinska [et al.] // Zentralbl Bakteriol. – 1994. – № 280. – Р. 348–359.
47. Huppertz, H.I. Lyme arthritis in European children and adolescents / H.I. Huppertz [et al.] // The Pediatric Rheumatology Collaborative Group. Arthritis Rheum. – 1995. – № 38. – Р. 361–368.
48. Kang, I. T-helper-cell cytokines in the early evolution of murine Lyme arthritis / I. Kang [et al.] // Infect Immun. – 1997. – V. 65, №8. – Р. 3107–3111.
49. Keil, R. Vasculitis course of neuroborreliosis with thalamic infarct/ R. Keil [et al.] // Nervenarzt. – 2007. – V. 68. – P. 339–341.
50. Klingebiel, R. Large cerebral vessel occlusive disease in Lyme neuroborreliosis / R. Klingebiel, G. Benndorf, M. Schmitt //Neuropediatrics. – 2009. – V. 33, №1. – Р. 37–40.
51. Kraiczy, P. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody / P. Kraiczy [et al.] // Int. J. Med. Microbiol. – 2002. – № 291 (Suppl. 33). – Р. 141–146.
52. Moriarty, T.J. Real-time high resolution 3D imaging of the lyme disease spirochete adhering to and escaping from the vasculature of a living host / T.J. Moriarty [et al.] // PLoS Pathog. – 2008. – V. 4, № 6. – Р. 1–13.
53. Müllegger, R.R. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans / R.R. Müllegger [et al.] // J. Invest. Dermatol. – 2000. – V. 115, № 6. – Р. 1115–1123.
54. Munksgaard, L. Demonstration of B. burgdorferi-DNA in two cases of nodal lymphoma / L. Munksgaard [et al.] // Leuk Lymphoma. – 2004. – № 45. – Р. 1721–1723.
55. Ohnishi, J. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks / J. Ohnishi, J. Piesman, A.M. de Silva // Proc. Natl. Acad. Sci. USA. – 2001. – № 98. – Р. 670–675.
56. Mursic, V.P. Formation and cultivationof Borrelia burgdorferi spheroplast-L-form variants / V.P. Mursic [et al.] // Infect. – 1996. – № 24. – Р. 218–226.
57. Nau, R. Lyme disease--current state of knowledge /R. Nau, H.J. Christen, H. Eiffert // Dtsch. Arztebl. Int. –2009. – V. 106, № 5. – Р. 72–81.
58. Pal, U. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands / U. Pal [et al.] // J. Clin. Invest. – 2004. – № 113. – Р. 220–330.
59. Pancewicz, S.A. Concentrations of pro-inflammatory cytokines IFN-gamma, IL-6, IL-12 and IL-15 in serum and cerebrospinal fluid in patients with neuroborreliosis undergoing antibiotic treatment / S.A. Pancewicz , M. Kondrusik, J. Zajkowska // Pol. Merkur. Lekarski. – 2007. – V. 22, № 130. – Р. 275–279.
60. Pausa, M. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59- like complement inhibitory molecule / M. Pausa [et al.] // Immunol. – 2003. – № 170. – Р. 3214–3222.
61. Ramesh, G. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis / G. Ramesh [et al.] // Am. J. Pathol. – 2008. – № 173. – Р. 1415–1427.
62. Ramesh, G. Possible role of glial cellsinthe onset and progression of Lyme neuroborreliosis / G. Ramesh, J.T. Borda, A. Gill // J. Neuroinflammation. – 2009. – № 6. – Р. 23.
63. Raveche, E.S. Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis / E.S. aveche, S.E. Schutzer, H. Fernandes // J. Clin. Microbiol. – 2005. – V. 43, № 2. – Р. 850–856.
64. Roberts, E.D. Pathogenesis of Lyme neuroborreliosis in the Rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system / E.D. Roberts [et al.] // J. Infect. Dis. – 1998. – № 178. – Р. 722–732.
65. Rupprecht, T.A. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis / T.A. Rupprecht [et al.] // Neurology. – 2005. – № 65. – Р. 448–450.
66. Schöllkopf, C. Borrelia infection and risk of non-Hodgkin lymphoma / C. Schöllkopf [et al.] // Blood. – 2008. – V. 111, № 12. – Р. 5524–5529.
67. Shapiro, E.D. Lyme disease / E.D. Shapiro, M.A. Gerber // Clin. Infect. Dis. – 2000. – № 31. – Р. 533–542.
68. Singh, S.K. Lyme borreliosis:from infection to autoimmunity / S.K. Singh, H.J. Girschick // Clin. Microbiol. Infect. – 2004. – № 10. – Р. 598–614.
69. Stanek, G. Lyme borreliosis / G. Stanek [et al.] // Lancet. – 2012. – V. 4. – № 379 (9814). – Р. 461–473.
70. Stanek, G. The explanding Lyme Borrelia complex – clinical significance of genomic species? / G. Stanek, M. Reiter // Clin. Microbiol. Infect. – 2011. – № 17. – Р. 487–493.
71. Stevenson, B. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi / B. Stevenson, T.G. Schwan, P.A. Rosa // Infect. Immun. – 1995. – № 63. – Р. 4535–4539.
72. Steere, A.C. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles / A.C. Steere, E. Dwyer, R. Winchester // N. Engl. J. Med. – 1990. – № 23. – Р. 219–223.
73. Steere, A.C. Lyme disease / A.C. Steere // N. Engl. J. Med. – 2001. – № 345. – Р. 115–125.
74. Topakian, R. Unexplained cerebral vasculitis and stroke: keep Lyme neuroborreliosis in mind / R. Topakian, K. Stieglbauer, F.T. Aichner // Lancet Neurol. – 2007. – V. 6, № 9. – P. 756–757.
75. Tilly, K. Rapid clearance of Lyme disease spirochetes lacking OspC from skin / K. Tilly [et al.] // Infect. Immun. – 2007. – № 75. – Р. 1517–1519.
76. Widhe, M. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome / M. Widhe [et al.] // J. Infect. Dis. – 2004. – V. 189, № 10. – Р. 1881–1891.
77. Wilke, M. Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: case reports and literature rewiew /M. Wilke [et al.] // Arch. Dis. Child. – 2000. – № 83. – P. 67–71.
78. Wilske, B. Lyme borreliosis in South Germany. Epidemiologic data on the incidence of cases and on the epidemiology of ticks (Ixodes ricinus) carrying Borrelia burgdorferi / B. Wilske [et al.] // Dtsch. Med. Wochenschr. – 1987. – № 112. – Р. 1730–1736.
79. Wutte, N. Serum CXCL13 chemokine is not a marker for active Lyme borreliosis / N. Wutte, А. Berghold, I. Krainberger [et al.] // Acta Derm Venereol. – 2011. –№ 91. – Р. 724–772.
80. Yssel, H. Borrelia burgdorferi activates a T helper type 1-like cell subset in Lyme arthritis / H. Yssel [et al.] // J. Exp. Med. – 1991. – № 174. – Р. 593–601.
81. Zabriskie, J.B. Rheumatic fever: a model for the pathological consequences of microbial-host mimicry / J.B. Zabriskie // Clin. Exp. Rheumatol. – 1986. – № 4. – Р. 65–73.
82. Zabriskie, J.B. The relationship of streptococcal crossreactive antigens to rheumatic fever / J.B. Zabriskie // Transplant. Proc. – 1969. – № 1. – Р. 968–975.
83. Zajkowska, J. Concentrations of soluble forms of adhesive particles: sVCAM-1, sPECAM-1, sVAP in early localized and late disseminated borreliosis / J. Zajkowska [et al.] // Pol Merkur Lekarski. – 2006. – V. 21, № 125. – Р. 459–464.
84. Zhang, L. Molecular interactions that enable movement of the Lyme disease agent from the tick gut into the hemolymph / L. Zhang, Y. Zhang, S. Adusumilli // PLoS Pathog. – 2011. – V. 7, № 6. – P. 12–16.
85. Официальный сайт Федеральной Службы в сфере защиты прав потребителей и благополучия человека. Инфекционная заболеваемость в Российской Федерации за январь-декабрь 2010 и 2011 гг. URL: http: // rospotrebnadzor.ru / epidemiologic_situation / (дата обращения: 20.01.2012).
86. Официальный сайт Центров по контролю и профилактике заболеваний (Centers for Disease Control and Prevention) URL: http://www.cdc.gov/lyme/stats/index.html (дата обращения: 20.02.2012).
Review
For citations:
Skripchenko N.V., Balinova A.A. Current knowledge of Lyme disease’s pathogenesis. Journal Infectology. 2012;4(2):5-14. (In Russ.) https://doi.org/10.22625/2072-6732-2012-4-2-5-14